img

Global GnRH Receptor Antagonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global GnRH Receptor Antagonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

GnRH antagonists are synthetic analogs of GnRH that bind to the GnRH receptors in the pituitary, rapidly suppressing the secretion of gonadotropins.
GnRH Receptor Antagonists report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global GnRH Receptor Antagonists market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Prostate Cancer and Endometriosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for GnRH Receptor Antagonists industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, GnRH Receptor Antagonists key manufacturers include AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals and Jiangsu Hengrui Medicine Co, etc. AbbVie, Takeda, Astellas are top 3 players and held % sales share in total in 2022.
GnRH Receptor Antagonists can be divided into Peptides and Small Molecules, etc. Peptides is the mainstream product in the market, accounting for % sales share globally in 2022.
GnRH Receptor Antagonists is widely used in various fields, such as Prostate Cancer, Endometriosis, Uterine Fibroids and Female Infertility, etc. Prostate Cancer provides greatest supports to the GnRH Receptor Antagonists industry development. In 2022, global % sales of GnRH Receptor Antagonists went into Prostate Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global GnRH Receptor Antagonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie
Takeda
Astellas
Kissei
Veru Inc
Myovant Sciences
AstraZeneca
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co
Segment by Type
Peptides
Small Molecules

Segment by Application


Prostate Cancer
Endometriosis
Uterine Fibroids
Female Infertility
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the GnRH Receptor Antagonists market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of GnRH Receptor Antagonists, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the GnRH Receptor Antagonists industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of GnRH Receptor Antagonists in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, GnRH Receptor Antagonists introduction, etc. GnRH Receptor Antagonists Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of GnRH Receptor Antagonists market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 GnRH Receptor Antagonists Market Overview
1.1 GnRH Receptor Antagonists Product Overview
1.2 GnRH Receptor Antagonists Market Segment by Type
1.2.1 Peptides
1.2.2 Small Molecules
1.3 Global GnRH Receptor Antagonists Market Size by Type
1.3.1 Global GnRH Receptor Antagonists Market Size Overview by Type (2018-2029)
1.3.2 Global GnRH Receptor Antagonists Historic Market Size Review by Type (2018-2024)
1.3.3 Global GnRH Receptor Antagonists Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America GnRH Receptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.2 Europe GnRH Receptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific GnRH Receptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.4 Latin America GnRH Receptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa GnRH Receptor Antagonists Sales Breakdown by Type (2018-2024)
2 Global GnRH Receptor Antagonists Market Competition by Company
2.1 Global Top Players by GnRH Receptor Antagonists Sales (2018-2024)
2.2 Global Top Players by GnRH Receptor Antagonists Revenue (2018-2024)
2.3 Global Top Players by GnRH Receptor Antagonists Price (2018-2024)
2.4 Global Top Manufacturers GnRH Receptor Antagonists Manufacturing Base Distribution, Sales Area, Product Type
2.5 GnRH Receptor Antagonists Market Competitive Situation and Trends
2.5.1 GnRH Receptor Antagonists Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by GnRH Receptor Antagonists Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in GnRH Receptor Antagonists as of 2022)
2.7 Date of Key Manufacturers Enter into GnRH Receptor Antagonists Market
2.8 Key Manufacturers GnRH Receptor Antagonists Product Offered
2.9 Mergers & Acquisitions, Expansion
3 GnRH Receptor Antagonists Status and Outlook by Region
3.1 Global GnRH Receptor Antagonists Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global GnRH Receptor Antagonists Historic Market Size by Region
3.2.1 Global GnRH Receptor Antagonists Sales in Volume by Region (2018-2024)
3.2.2 Global GnRH Receptor Antagonists Sales in Value by Region (2018-2024)
3.2.3 Global GnRH Receptor Antagonists Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global GnRH Receptor Antagonists Forecasted Market Size by Region
3.3.1 Global GnRH Receptor Antagonists Sales in Volume by Region (2024-2029)
3.3.2 Global GnRH Receptor Antagonists Sales in Value by Region (2024-2029)
3.3.3 Global GnRH Receptor Antagonists Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global GnRH Receptor Antagonists by Application
4.1 GnRH Receptor Antagonists Market Segment by Application
4.1.1 Prostate Cancer
4.1.2 Endometriosis
4.1.3 Uterine Fibroids
4.1.4 Female Infertility
4.1.5 Others
4.2 Global GnRH Receptor Antagonists Market Size by Application
4.2.1 Global GnRH Receptor Antagonists Market Size Overview by Application (2018-2029)
4.2.2 Global GnRH Receptor Antagonists Historic Market Size Review by Application (2018-2024)
4.2.3 Global GnRH Receptor Antagonists Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America GnRH Receptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.2 Europe GnRH Receptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific GnRH Receptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.4 Latin America GnRH Receptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa GnRH Receptor Antagonists Sales Breakdown by Application (2018-2024)
5 North America GnRH Receptor Antagonists by Country
5.1 North America GnRH Receptor Antagonists Historic Market Size by Country
5.1.1 North America GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America GnRH Receptor Antagonists Sales in Volume by Country (2018-2024)
5.1.3 North America GnRH Receptor Antagonists Sales in Value by Country (2018-2024)
5.2 North America GnRH Receptor Antagonists Forecasted Market Size by Country
5.2.1 North America GnRH Receptor Antagonists Sales in Volume by Country (2024-2029)
5.2.2 North America GnRH Receptor Antagonists Sales in Value by Country (2024-2029)
6 Europe GnRH Receptor Antagonists by Country
6.1 Europe GnRH Receptor Antagonists Historic Market Size by Country
6.1.1 Europe GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe GnRH Receptor Antagonists Sales in Volume by Country (2018-2024)
6.1.3 Europe GnRH Receptor Antagonists Sales in Value by Country (2018-2024)
6.2 Europe GnRH Receptor Antagonists Forecasted Market Size by Country
6.2.1 Europe GnRH Receptor Antagonists Sales in Volume by Country (2024-2029)
6.2.2 Europe GnRH Receptor Antagonists Sales in Value by Country (2024-2029)
7 Asia-Pacific GnRH Receptor Antagonists by Region
7.1 Asia-Pacific GnRH Receptor Antagonists Historic Market Size by Region
7.1.1 Asia-Pacific GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific GnRH Receptor Antagonists Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific GnRH Receptor Antagonists Sales in Value by Region (2018-2024)
7.2 Asia-Pacific GnRH Receptor Antagonists Forecasted Market Size by Region
7.2.1 Asia-Pacific GnRH Receptor Antagonists Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific GnRH Receptor Antagonists Sales in Value by Region (2024-2029)
8 Latin America GnRH Receptor Antagonists by Country
8.1 Latin America GnRH Receptor Antagonists Historic Market Size by Country
8.1.1 Latin America GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America GnRH Receptor Antagonists Sales in Volume by Country (2018-2024)
8.1.3 Latin America GnRH Receptor Antagonists Sales in Value by Country (2018-2024)
8.2 Latin America GnRH Receptor Antagonists Forecasted Market Size by Country
8.2.1 Latin America GnRH Receptor Antagonists Sales in Volume by Country (2024-2029)
8.2.2 Latin America GnRH Receptor Antagonists Sales in Value by Country (2024-2029)
9 Middle East and Africa GnRH Receptor Antagonists by Country
9.1 Middle East and Africa GnRH Receptor Antagonists Historic Market Size by Country
9.1.1 Middle East and Africa GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa GnRH Receptor Antagonists Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa GnRH Receptor Antagonists Sales in Value by Country (2018-2024)
9.2 Middle East and Africa GnRH Receptor Antagonists Forecasted Market Size by Country
9.2.1 Middle East and Africa GnRH Receptor Antagonists Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa GnRH Receptor Antagonists Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AbbVie GnRH Receptor Antagonists Products Offered
10.1.5 AbbVie Recent Development
10.2 Takeda
10.2.1 Takeda Company Information
10.2.2 Takeda Introduction and Business Overview
10.2.3 Takeda GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Takeda GnRH Receptor Antagonists Products Offered
10.2.5 Takeda Recent Development
10.3 Astellas
10.3.1 Astellas Company Information
10.3.2 Astellas Introduction and Business Overview
10.3.3 Astellas GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Astellas GnRH Receptor Antagonists Products Offered
10.3.5 Astellas Recent Development
10.4 Kissei
10.4.1 Kissei Company Information
10.4.2 Kissei Introduction and Business Overview
10.4.3 Kissei GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Kissei GnRH Receptor Antagonists Products Offered
10.4.5 Kissei Recent Development
10.5 Veru Inc
10.5.1 Veru Inc Company Information
10.5.2 Veru Inc Introduction and Business Overview
10.5.3 Veru Inc GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Veru Inc GnRH Receptor Antagonists Products Offered
10.5.5 Veru Inc Recent Development
10.6 Myovant Sciences
10.6.1 Myovant Sciences Company Information
10.6.2 Myovant Sciences Introduction and Business Overview
10.6.3 Myovant Sciences GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Myovant Sciences GnRH Receptor Antagonists Products Offered
10.6.5 Myovant Sciences Recent Development
10.7 AstraZeneca
10.7.1 AstraZeneca Company Information
10.7.2 AstraZeneca Introduction and Business Overview
10.7.3 AstraZeneca GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.7.4 AstraZeneca GnRH Receptor Antagonists Products Offered
10.7.5 AstraZeneca Recent Development
10.8 Ferring Pharmaceuticals
10.8.1 Ferring Pharmaceuticals Company Information
10.8.2 Ferring Pharmaceuticals Introduction and Business Overview
10.8.3 Ferring Pharmaceuticals GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Ferring Pharmaceuticals GnRH Receptor Antagonists Products Offered
10.8.5 Ferring Pharmaceuticals Recent Development
10.9 Jiangsu Hengrui Medicine Co
10.9.1 Jiangsu Hengrui Medicine Co Company Information
10.9.2 Jiangsu Hengrui Medicine Co Introduction and Business Overview
10.9.3 Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Products Offered
10.9.5 Jiangsu Hengrui Medicine Co Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 GnRH Receptor Antagonists Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 GnRH Receptor Antagonists Industrial Chain Analysis
11.4 GnRH Receptor Antagonists Market Dynamics
11.4.1 GnRH Receptor Antagonists Industry Trends
11.4.2 GnRH Receptor Antagonists Market Drivers
11.4.3 GnRH Receptor Antagonists Market Challenges
11.4.4 GnRH Receptor Antagonists Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 GnRH Receptor Antagonists Distributors
12.3 GnRH Receptor Antagonists Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Peptides
Table 2. Major Company of Small Molecules
Table 3. Global GnRH Receptor Antagonists Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global GnRH Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 5. Global GnRH Receptor Antagonists Sales Market Share in Volume by Type (2018-2024)
Table 6. Global GnRH Receptor Antagonists Sales by Type (2018-2024) & (US& Million)
Table 7. Global GnRH Receptor Antagonists Market Share in Value by Type (2018-2024)
Table 8. Global GnRH Receptor Antagonists Price by Type (2018-2024) & (USD/Unit)
Table 9. Global GnRH Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 10. Global GnRH Receptor Antagonists Sales Market Share in Volume by Type (2024-2029)
Table 11. Global GnRH Receptor Antagonists Sales by Type (2024-2029) & (US$ Million)
Table 12. Global GnRH Receptor Antagonists Sales Market Share in Value by Type (2024-2029)
Table 13. Global GnRH Receptor Antagonists Price by Type (2024-2029) & (USD/Unit)
Table 14. North America GnRH Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 15. North America GnRH Receptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe GnRH Receptor Antagonists Sales (K Units) by Type (2018-2024)
Table 17. Europe GnRH Receptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific GnRH Receptor Antagonists Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific GnRH Receptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America GnRH Receptor Antagonists Sales (K Units) by Type (2018-2024)
Table 21. Latin America GnRH Receptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa GnRH Receptor Antagonists Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa GnRH Receptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 24. Global GnRH Receptor Antagonists Sales by Company (2018-2024) & (K Units)
Table 25. Global GnRH Receptor Antagonists Sales Share by Company (2018-2024)
Table 26. Global GnRH Receptor Antagonists Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global GnRH Receptor Antagonists Revenue Share by Company (2018-2024)
Table 28. Global Market GnRH Receptor Antagonists Price by Company (2018-2024) & (USD/Unit)
Table 29. Global GnRH Receptor Antagonists Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global GnRH Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in GnRH Receptor Antagonists as of 2022)
Table 32. Date of Key Manufacturers Enter into GnRH Receptor Antagonists Market
Table 33. Key Manufacturers GnRH Receptor Antagonists Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global GnRH Receptor Antagonists Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global GnRH Receptor Antagonists Sales by Region (2018-2024) & (K Units)
Table 37. Global GnRH Receptor Antagonists Sales Market Share in Volume by Region (2018-2024)
Table 38. Global GnRH Receptor Antagonists Sales by Region (2018-2024) & (US$ Million)
Table 39. Global GnRH Receptor Antagonists Sales Market Share in Value by Region (2018-2024)
Table 40. Global GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global GnRH Receptor Antagonists Sales by Region (2024-2029) & (K Units)
Table 42. Global GnRH Receptor Antagonists Sales Market Share in Volume by Region (2024-2029)
Table 43. Global GnRH Receptor Antagonists Sales by Region (2024-2029) & (US$ Million)
Table 44. Global GnRH Receptor Antagonists Sales Market Share in Value by Region (2024-2029)
Table 45. Global GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 46. Global GnRH Receptor Antagonists Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global GnRH Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 48. Global GnRH Receptor Antagonists Sales Market Share in Volume by Application (2018-2024)
Table 49. Global GnRH Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 50. Global GnRH Receptor Antagonists Sales Market Share in Value by Application (2018-2024)
Table 51. Global GnRH Receptor Antagonists Price by Application (2018-2024) & (USD/Unit)
Table 52. Global GnRH Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 53. Global GnRH Receptor Antagonists Sales Market Share in Volume by Application (2024-2029)
Table 54. Global GnRH Receptor Antagonists Sales by Application (2024-2029) & (US$ Million)
Table 55. Global GnRH Receptor Antagonists Sales Market Share in Value by Application (2024-2029)
Table 56. Global GnRH Receptor Antagonists Price by Application (2024-2029) & (USD/Unit)
Table 57. North America GnRH Receptor Antagonists Sales by Application (2018-2024) (K Units)
Table 58. North America GnRH Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe GnRH Receptor Antagonists Sales by Application (2018-2024) (K Units)
Table 60. Europe GnRH Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific GnRH Receptor Antagonists Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific GnRH Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America GnRH Receptor Antagonists Sales by Application (2018-2024) (K Units)
Table 64. Latin America GnRH Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa GnRH Receptor Antagonists Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa GnRH Receptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 67. North America GnRH Receptor Antagonists Sales by Country (2018-2024) & (K Units)
Table 68. North America GnRH Receptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 69. North America GnRH Receptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 70. North America GnRH Receptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 71. North America GnRH Receptor Antagonists Sales by Country (2024-2029) & (K Units)
Table 72. North America GnRH Receptor Antagonists Sales Market Share in Volume by Country (2024-2029)
Table 73. North America GnRH Receptor Antagonists Sales by Country (2024-2029) & (US$ Million)
Table 74. North America GnRH Receptor Antagonists Sales Market Share in Value by Country (2024-2029)
Table 75. Europe GnRH Receptor Antagonists Sales by Country (2018-2024) & (K Units)
Table 76. Europe GnRH Receptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe GnRH Receptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe GnRH Receptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 79. Europe GnRH Receptor Antagonists Sales by Country (2024-2029) & (K Units)
Table 80. Europe GnRH Receptor Antagonists Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe GnRH Receptor Antagonists Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe GnRH Receptor Antagonists Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific GnRH Receptor Antagonists Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific GnRH Receptor Antagonists Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific GnRH Receptor Antagonists Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific GnRH Receptor Antagonists Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America GnRH Receptor Antagonists Sales by Country (2018-2024) & (K Units)
Table 92. Latin America GnRH Receptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America GnRH Receptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America GnRH Receptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America GnRH Receptor Antagonists Sales by Country (2024-2029) & (K Units)
Table 96. Latin America GnRH Receptor Antagonists Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America GnRH Receptor Antagonists Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America GnRH Receptor Antagonists Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa GnRH Receptor Antagonists Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa GnRH Receptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa GnRH Receptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa GnRH Receptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa GnRH Receptor Antagonists Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa GnRH Receptor Antagonists Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa GnRH Receptor Antagonists Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa GnRH Receptor Antagonists Sales Market Share in Value by Country (2024-2029)
Table 107. AbbVie Company Information
Table 108. AbbVie Introduction and Business Overview
Table 109. AbbVie GnRH Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. AbbVie GnRH Receptor Antagonists Product
Table 111. AbbVie Recent Development
Table 112. Takeda Company Information
Table 113. Takeda Introduction and Business Overview
Table 114. Takeda GnRH Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Takeda GnRH Receptor Antagonists Product
Table 116. Takeda Recent Development
Table 117. Astellas Company Information
Table 118. Astellas Introduction and Business Overview
Table 119. Astellas GnRH Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Astellas GnRH Receptor Antagonists Product
Table 121. Astellas Recent Development
Table 122. Kissei Company Information
Table 123. Kissei Introduction and Business Overview
Table 124. Kissei GnRH Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Kissei GnRH Receptor Antagonists Product
Table 126. Kissei Recent Development
Table 127. Veru Inc Company Information
Table 128. Veru Inc Introduction and Business Overview
Table 129. Veru Inc GnRH Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Veru Inc GnRH Receptor Antagonists Product
Table 131. Veru Inc Recent Development
Table 132. Myovant Sciences Company Information
Table 133. Myovant Sciences Introduction and Business Overview
Table 134. Myovant Sciences GnRH Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Myovant Sciences GnRH Receptor Antagonists Product
Table 136. Myovant Sciences Recent Development
Table 137. AstraZeneca Company Information
Table 138. AstraZeneca Introduction and Business Overview
Table 139. AstraZeneca GnRH Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. AstraZeneca GnRH Receptor Antagonists Product
Table 141. AstraZeneca Recent Development
Table 142. Ferring Pharmaceuticals Company Information
Table 143. Ferring Pharmaceuticals Introduction and Business Overview
Table 144. Ferring Pharmaceuticals GnRH Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Ferring Pharmaceuticals GnRH Receptor Antagonists Product
Table 146. Ferring Pharmaceuticals Recent Development
Table 147. Jiangsu Hengrui Medicine Co Company Information
Table 148. Jiangsu Hengrui Medicine Co Introduction and Business Overview
Table 149. Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Product
Table 151. Jiangsu Hengrui Medicine Co Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. GnRH Receptor Antagonists Market Trends
Table 155. GnRH Receptor Antagonists Market Drivers
Table 156. GnRH Receptor Antagonists Market Challenges
Table 157. GnRH Receptor Antagonists Market Restraints
Table 158. GnRH Receptor Antagonists Distributors List
Table 159. GnRH Receptor Antagonists Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. GnRH Receptor Antagonists Product Picture
Figure 2. Global GnRH Receptor Antagonists Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global GnRH Receptor Antagonists Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global GnRH Receptor Antagonists Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Peptides
Figure 6. Global Peptides Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Small Molecules
Figure 8. Global Small Molecules Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global GnRH Receptor Antagonists Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global GnRH Receptor Antagonists Sales Market Share by Type in 2022 & 2029
Figure 11. North America GnRH Receptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 12. North America GnRH Receptor Antagonists Sales Market Share in Value by Type in 2022
Figure 13. Europe GnRH Receptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 14. Europe GnRH Receptor Antagonists Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Value by Type in 2022
Figure 17. Latin America GnRH Receptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 18. Latin America GnRH Receptor Antagonists Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa GnRH Receptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa GnRH Receptor Antagonists Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by GnRH Receptor Antagonists Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by GnRH Receptor Antagonists Revenue in 2022
Figure 23. GnRH Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Prostate Cancer
Figure 25. Global Prostate Cancer Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Endometriosis
Figure 27. Global Endometriosis Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Uterine Fibroids
Figure 29. Global Uterine Fibroids Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Female Infertility
Figure 31. Global Female Infertility Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global GnRH Receptor Antagonists Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global GnRH Receptor Antagonists Sales Market Share by Application in 2022 & 2029
Figure 36. North America GnRH Receptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 37. North America GnRH Receptor Antagonists Sales Market Share in Value by Application in 2022
Figure 38. Europe GnRH Receptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 39. Europe GnRH Receptor Antagonists Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Value by Application in 2022
Figure 42. Latin America GnRH Receptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 43. Latin America GnRH Receptor Antagonists Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa GnRH Receptor Antagonists Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. GnRH Receptor Antagonists Manufacturing Cost Structure
Figure 47. GnRH Receptor Antagonists Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries